1. Home
  2. KYMR vs UAA Comparison

KYMR vs UAA Comparison

Compare KYMR & UAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYMR
  • UAA
  • Stock Information
  • Founded
  • KYMR 2015
  • UAA 1996
  • Country
  • KYMR United States
  • UAA United States
  • Employees
  • KYMR N/A
  • UAA N/A
  • Industry
  • KYMR Medicinal Chemicals and Botanical Products
  • UAA Apparel
  • Sector
  • KYMR Health Care
  • UAA Consumer Discretionary
  • Exchange
  • KYMR Nasdaq
  • UAA Nasdaq
  • Market Cap
  • KYMR 2.7B
  • UAA 3.1B
  • IPO Year
  • KYMR 2020
  • UAA N/A
  • Fundamental
  • Price
  • KYMR $36.81
  • UAA $7.10
  • Analyst Decision
  • KYMR Buy
  • UAA Hold
  • Analyst Count
  • KYMR 15
  • UAA 22
  • Target Price
  • KYMR $55.27
  • UAA $9.00
  • AVG Volume (30 Days)
  • KYMR 456.1K
  • UAA 11.4M
  • Earning Date
  • KYMR 02-27-2025
  • UAA 02-06-2025
  • Dividend Yield
  • KYMR N/A
  • UAA N/A
  • EPS Growth
  • KYMR N/A
  • UAA N/A
  • EPS
  • KYMR N/A
  • UAA N/A
  • Revenue
  • KYMR $87,563,000.00
  • UAA $5,315,924,000.00
  • Revenue This Year
  • KYMR N/A
  • UAA N/A
  • Revenue Next Year
  • KYMR $32.89
  • UAA $1.28
  • P/E Ratio
  • KYMR N/A
  • UAA N/A
  • Revenue Growth
  • KYMR 86.92
  • UAA N/A
  • 52 Week Low
  • KYMR $29.24
  • UAA $6.17
  • 52 Week High
  • KYMR $53.27
  • UAA $11.89
  • Technical
  • Relative Strength Index (RSI)
  • KYMR 42.51
  • UAA 32.14
  • Support Level
  • KYMR $36.67
  • UAA $7.05
  • Resistance Level
  • KYMR $38.24
  • UAA $7.36
  • Average True Range (ATR)
  • KYMR 1.78
  • UAA 0.30
  • MACD
  • KYMR 0.06
  • UAA -0.03
  • Stochastic Oscillator
  • KYMR 51.81
  • UAA 4.01

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.

About UAA Under Armour Inc.

Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and elsewhere. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. Under Armour also operates a digital fitness app called MapMyFitness. The Baltimore-based company was founded in 1996 and is led by controlling shareholder Kevin Plank.

Share on Social Networks: